Fukuoka Biotech-AI Hub

A network of regional startup and innovation hubs mitigating Tokyo-Osaka concentration. Fukuoka, Kyoto, Hiroshima, Sendai, and others leverage unique technological strengths to advance local AI, biotech, and smart city projects. A Japanese innovation strategy balancing regional economic revitalization with global competitiveness.

A convergence research hub of life sciences and AI centered in Fukuoka City. Brings together Kyushu University, medical institutions, and biotech companies. Develops technologies for telemedicine diagnosis, personalized medicine AI, and protein analysis. Emerging as a regional model for next-generation technology innovation outside major metropolitan areas.

A network of regional startup and innovation hubs mitigating Tokyo-Osaka concentration. Fukuoka, Kyoto, Hiroshima, Sendai, and others leverage unique technological strengths to advance local AI, biotech, and smart city projects. A Japanese innovation strategy balancing regional economic revitalization with global competitiveness.

A vision for a super-smart society advocated by the Japanese government. It aims to create a human-centered society that balances economic development with solving social challenges by deeply integrating cyberspace and physical space. It is positioned as the fifth societal model following hunting, agrarian, industrial, and information societies.

Japan's autonomous driving technology development and social implementation. Major automakers like Toyota, Honda, and Nissan are joined by startups like Tier IV. It is expected to address social challenges including securing transportation in depopulated areas.

Promotion of government digitalization through the Digital Agency established in 2021 and the My Number system. Efforts include expanding My Number card adoption, digitalizing administrative procedures, and building data integration infrastructure. It functions as the cornerstone of Japan's digital transformation.

Medical innovation in Japan leveraging technology, including online consultations and AI image diagnostics. Regulations on telemedicine were relaxed during the COVID-19 pandemic, accelerating adoption. It is expected to improve healthcare access and control medical costs in an aging society.